Clinical Advances in Gastrointestinal Inflammation
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 20 August 2025 | Viewed by 499
Special Issue Editor
2. Department of Health Studies, University of Split, Split, Croatia
Interests: gastrointestinal infections; Helicobacter pylori infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Gastrointestinal inflammation includes a wide spectrum of diseases from acute to chronic inflammatory processes of the gastrointestinal tract.
Helicobacter pylori is the most prevalent chronic bacterial infection, with approximately half of the world's population estimated to be colonized. Along with the worldwide antibiotic resistance trends, eradication rates are declining, while resistance rates of H. pylori are increasing, and eradication is becoming increasingly difficult.
For the above reasons, H. pylori is the most important gastrointestinal infection; therefore, this Special Issue, “Clinical Advances in Gastrointestinal Inflammation”, is specially dedicated to H. pylori infection. Following the COVID-19 pandemic and the widespread use of antibiotic therapies, we can expect new challenges in the treatment of H. pylori and the rise in antibiotic resistance.
In this Special Issue, we would like to emphasize the challenges of treating inflammatory bowel diseases, especially regarding the COVID-19 pandemic, which certainly had consequences for these patients during the pandemic. Therefore, research during the pandemic as well as in the post-COVID era is very important.
Research regarding acute gastrointestinal infections as well as celiac disease is welcome.
The suggested topics for this Special Issue are:
- Challenges of treating H. pylori infection following the COVID-19 pandemic.
- Challenges of treating inflammatory bowel diseases during and following the COVID-19 pandemic.
- Challenges of treating acute gastrointestinal infections in the post-COVID era.
- Challenges of treating celiac disease during and following the COVID-19 pandemic.
- SARS-CoV-2-induced gastrointestinal diseases.
I hope that you will find the proposed topics suitable for this Special Issue, “Clinical Advances in Gastrointestinal Inflammation”, in JCM.
Dr. Ivana Jukic
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Helicobacter pylori
- antibiotic resistance
- COVID-19 pandemic
- post-COVID era
- inflammatory bowel diseases
- acute gastrointestinal infections
- SARS-COV-2 infection
- celiac disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
